web statistics

Main Portal | Chemotherapy Articles | Chemotherapy Links | Chemotherapy Partners | Chemotherapy Sitemap

Index of All Articles in the Chemotherapy Treatments Category


Defined Tag:


It’s Okay to Get Help During Chemotherapy Treatments

Cancer can be a scary word for those who are diagnosed with some form of the illness But it is not just scary to you your family must deal with your illness as well This is true when you are having your chemotherapy treatments as well You need not stay awa
Read More...






Other green Health Medical Topics To Check Out:
acupuncture acupressure drug addiction prescription
free DNA test general hospital happening
hysterectomy recovery laboratory equipment supply
nursing job part of a microscope
surgery information wheelchair
Early Menopause Symptom alcohol abuse symptom
lyme disease symptom teeth whitening
chemotherapy side effects senior health care
alzheimers symptom sterile processing environment
geriatric doctor  


























Chemotherapy News and Events

Medical Power Search

Our specialised search engine is designed to look for the right information for your health search enquiry. Type in your search key now and Medical Power Search will return you laser-targetted search results to match your needs.
 
 
 


U.S. Phase 2 Combination Clinical Trial For Non-Small Cell Lung Cancer Patients With K-RAS Or EGFR-Activated Tumours (Medical News Today)

Wed, 03 Sep 2008 11:10:02 GMT

Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced that following U.S. Food and Drug Administration (FDA) review, the Company is initiating a U.S. Phase 2 clinical trial using intravenous administration of REOLYSIN(R) in combination with paclitaxel and carboplatin in patients with non-small cell lung cancer (NSCLC) with K-RAS or EGFR-activated tumours.


Oncolytics initiates US Phase II lung cancer trial (Pharmaceutical Business Review)

Wed, 03 Sep 2008 00:39:51 GMT

Oncolytics Biotech has announced that following the FDA review, the company is initiating a US Phase II clinical trial using intravenous administration of Reolysin in combination with paclitaxel and carboplatin in patients with non-small cell lung cancer with K-RAS or EGFR-activated tumors.


Cytopia Commences Second Phase II Study In Brain Cancer (Medical News Today)

Fri, 05 Sep 2008 10:14:43 GMT

Cytopia Limited (ASX:CYT) announced that it is commencing enrolment for its Phase Ib/II study of CYT997, the company's novel vascular-disrupting anticancer agent, in patients with an aggressive form of brain cancer known as glioblastoma multiforme (GBM).






© 2008, Chemotherapy - All Rights Reserved Worldwide | Chemotherapy Legal Information